DRREDDY's weekly performance was modest, with a 1.43% return, outperforming HINDUNILVR but underperforming DIVISLAB and SUNPHARMA. The stock's volatility was relatively low at 6.53%, indicating a relatively stable week. The Sharpe Ratio of 0.87 suggests that the return was decent considering the risk taken. Overall, DRREDDY had a decent week, but its performance was eclipsed by SUNPHARMA's strong return.

[Volatility: 6.53%]